The table below shows NOVAVAX INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$244.63M
-$87.26M
-$713.97M
-$415.94M
$322.95M
-$42.54M
Capital expenditure
-
-
-
-
-
-
Investing cash flow
-$78.27M
-$204.04M
-$58.81M
-$92.98M
$100.15M
-$377.78M
Dividends paid
-
-
-
-
-
NVAX operating cash flow (10-K history)
NOVAVAX INC reported operating cash flow of -$244.63M for fiscal year 2025. That is down 180.3% from -$87.26M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$258.77M (FY 2016) to -$244.63M. Figures come from the company's audited annual reports as filed with the SEC.
